Informational Studies About Medical Marijuana Are Lacking
Researchers surveyed random sample of 400 oncologists to asses their views and practices with medical marijuana.
Researchers surveyed random sample of 400 oncologists to asses their views and practices with medical marijuana.
A survey of pediatric oncology providers including physicians, nurses, and social workers reveals their willingness to consider medical marijuana for children with cancer, as well as their reasons against its use in these patients.
Investigators report that administering cannabis to patients with cancer undergoing immunotherapy was found to lower the response rate to therapy but had no effect on PFS or OS, in an oral presentation at ESMO 2017 Congress.
Despite recent new legislation, medical marijuana as an adjunct to palliative and end-of-life care remains controversial. But a greater acceptance within both the medical community and the lay public is prompting research on how it can be integrated into standard care.
Using data from previous analyses and several state medical cannabis programs, investigators assessed how social attitudes, health issues, and state laws affect the use of cannabis among persons older than 50 years.
Oral cannabinoids can ease chronic pain and chemotherapy-related nausea, but researchers cite risks, as well.
Pain response—sensitivity and tolerance—after use of active cannabis differs between men and women.
Patients periodically ask about the use of marijuana in cancer treatment. Is there any data about this?
Clinically relevant psychotropic side effects plus ineffectiveness halted study of cannabis use to prevent postoperative nausea.
Moderate lifetime marijuana use is associated with airway inflammation, but not significant changes in lung function.